Prescription Drug Abuse and Workplace Absenteeism: Evidence from the 2008–2012 National Survey on Drug Use and Health

Hasselt, Martijn van; Keyes, Vincent; Bray, Jeremy; Miller, Ted R.

doi:10.1080/15555240.2015.1047499

Cited by 27 publications

(18 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous researchers have estimated the overall societal impact of prescription opioid misuse (6, 7). Other studies have examined specific components of the overall issue of opioid misuse, such as the cost of poisonings, nonmedical use (8), and abuse and workplace absenteeism(9). Most recently, Birnbaum et al (10) estimated the overall societal impact of prescription opioid abuse, dependence and misuse in the United States to be $55.7 billion in 2007.…”

Section: Introductionmentioning

confidence: 99%

The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

Florence

Zhou²,

Luo³

et al. 2016

Medical Care

1,051

658

View full text Add to dashboard Cite

Importance It is important to understand the magnitude and distribution of the economic burden of prescription opioid overdose, abuse and dependence to inform clinical practice, research and other decision makers. Decision makers choosing approaches to address this epidemic need cost information to evaluate the cost effectiveness of their choices. Objective To estimate the economic burden of prescription opioid overdose, abuse, and dependence from a societal perspective Design, Setting and Participants Incidence of fatal prescription opioid overdose from the National Vital Statistics System, prevalence of abuse and dependence from the National Survey of Drug Use and Health. Fatal data are for the U.S population, nonfatal data are is a nationally representative sample of the U.S. civilian noninstitutionalized population ages 12 and older. Cost data are from various sources including health care claims data from the Truven Health MarketScan® Research Databases, and cost of fatal cases from the WISQARS™ (Web-based Injury Statistics Query and Reporting System) cost module. Criminal justice costs were derived from the Justice Expenditure and Employment Extracts published by the Department of Justice. Estimates of lost productivity were based on a previously published study. Exposure Calendar year 2013 Main Outcomes and Measures Monetized burden of fatal overdose and abuse and dependence of prescription opioids. Results The total economic burden is estimated to be $78.5 billion. Over one third of this amount (is due to increased health care and substance abuse treatment costs ($28.9 billion). Approximately one quarter of the cost is borne by the public sector in health care, substance abuse treatment, and criminal justice costs. Conclusions and Relevance These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence.

show abstract

Section: Introductionmentioning

confidence: 99%

The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

Florence

Zhou²,

Luo³

et al. 2016

Medical Care

1,051

658

View full text Add to dashboard Cite

show abstract

“…26 Similarly, workers with substance use concerns have more absenteeism, which has major economic ramifications. 27,28 Aside from these diagnosable (and of note, treatable) behavioral health disorders, employers recognize the importance of promoting mental health. Companies have begun to create positions such as chief wellness or well-being officers, and the role of burnout in contributing to diminished productivity has become a widely studied topic across multiple work sectors.…”

Section: Why Employers Should Care About Employee Mental Healthmentioning

confidence: 99%